Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 201 |
Ghisallo Capital Management
Boston,
Massachusetts
| $72.2M | +$60.9M | 8 | 1.42% | Increased |
|
| 202 |
Erste Asset Management
Vienna,
Austria
| $72M | -$16.9M | 12 | 0.56% | Reduced |
|
| 203 |
Harvest Portfolios Group
Oakville,
Ontario, Canada
| $71.6M | +$354K | 1 | 1.01% | Increased |
|
| 204 |
Cerity Partners
New York
| $70.4M | +$3.44M | 23 | 0.09% | Increased |
|
| 205 |
DC
Diametric Capital
Boston,
Massachusetts
| $68.6M | +$14.1M | 8 | 7.24% | Increased |
|
| 206 |
Boston Partners
Boston,
Massachusetts
| $67M | +$4.91M | 2 | 0.06% | Increased |
|
| 207 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| $66.8M | -$3.43M | 39 | 0.06% | Reduced |
|
| 208 |
Two Seas Capital
Rye,
New York
| $66.4M | +$3.7M | 1 | 1.32% | Increased |
|
| 209 |
TimesSquare Capital Management
New York
| $65.9M | -$1.26M | 2 | 0.97% | Reduced |
|
| 210 |
PM
Prosight Management
Dallas,
Texas
| $65.9M | -$15.7M | 4 | 11.35% | Reduced |
|
| 211 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
| $65.6M | -$22.4M | 7 | 3.2% | Reduced |
|
| 212 |
Boston Trust Walden
Boston,
Massachusetts
| $65.5M | +$622K | 1 | 0.5% | Increased |
|
| 213 |
BC
Broadwood Capital
New York
| $64.9M | $0 | 1 | 3.39% | Maintained |
|
| 214 |
Maverick Capital
Dallas,
Texas
| $64.7M | +$7.62M | 5 | 0.57% | Increased |
|
| 215 |
Osaic Holdings
Scottsdale,
Arizona
| $64.6M | +$5.05M | 68 | 0.08% | Increased |
|
| 216 |
Nomura Holdings
Tokyo,
Japan
| $64M | +$14.4M | 6 | 0.08% | Increased |
|
| 217 |
Snyder Capital Management
San Francisco,
California
| $63.9M | +$7.84M | 1 | 1.1% | Increased |
|
| 218 |
Blackstone Inc
New York
| $63.8M | +$23.9M | 7 | 0.16% | Increased |
|
| 219 |
Jump Financial
Chicago,
Illinois
| $63.4M | +$12.2M | 24 | 0.51% | Increased |
|
| 220 |
RP
Regeneron Pharmaceuticals
Tarrytown,
New York
| $63.2M | $0 | 2 | 35.65% | Maintained |
|
| 221 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
| $63.2M | +$4.7M | 8 | 8.24% | Increased |
|
| 222 |
Trexquant Investment
Stamford,
Connecticut
| $62.5M | +$8.32M | 17 | 0.37% | Increased |
|
| 223 |
B
Braidwell
Stamford,
Connecticut
| $61.8M | -$24.8M | 2 | 2.29% | Reduced |
|
| 224 |
TCTC Holdings
Dallas,
Texas
| $61.7M | +$10.2K | 1 | 1.62% | Increased |
|
| 225 |
AAA
Affinity Asset Advisors
New York
| $58.6M | -$42M | 6 | 2.65% | Reduced |
|